
Evonik cancels IPO
CVC-backed German chemicals maker Evonik has announced the cancellation of its planned IPO.
The Company, which is 25% owned by CVC and at 75% by the German RAG Foundation, was due to float early this summer but withdrew its pending offer yesterday. Board members cited a "high level of uncertainty" in the markets for the decision.
This is the second time Evonik has canceled a planned IPO, having shelved the option last year already. The company would have entered Frankfurt's benchmark DAX index and shareholders had hoped to achieve a market cap of between €10-15bn, according to reports.
The flotation was intended to secure income to cover the liabilities associated with the ending of subsidised coal mining in Germany in 2018. Evonik had revenues of €14.5bn last year, generating an EBITDA of €2.8bn.
A spokesperson for the RAG Foundation said in a statement: "Evonik remains in excellent shape. However, its IPO can be considered only upon a significant improvement of the situation in the financial markets."
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater